Indian F&O data, and the evidence about what not to trade · educational
DIVISLAB · Healthcare
1M / 3M / 1Y
+15.4% / +43.9% / +54.4%
Traded value (60d med)
₹291 cr
Days in F&O ban since 2020
0
Futures OI / 1d change
3.2M / +0.1M
ATM implied vol
21% (vs 27% realized)
📜 Results-day history
Typical move 1.8% · up on the day 48% of 27 events · moved 4%+ in 22% · worst -6.1% / best +12.0%
| Reaction day | Move | Open gap | Next 5d | Announced |
|---|
| 2026-07-22 | +0.8% | +0.0% | +5.4% | after close |
| 2026-04-27 | +1.8% | -0.2% | +2.2% | during mkt |
| 2026-01-27 | +0.7% | +0.9% | +2.5% | during mkt |
| 2025-10-17 | +0.3% | -0.3% | -0.4% | during mkt |
| 2025-07-21 | -0.6% | +0.2% | -1.6% | during mkt |
| 2025-04-24 | +4.9% | +1.0% | -1.8% | during mkt |
| 2025-02-04 | +3.6% | +2.8% | -2.5% | after close |
| 2024-11-11 | -0.8% | +3.4% | +0.0% | during mkt |
Educational data reference: NOT investment advice. Historical statistics do not predict future results. We are not SEBI-registered advisers. All data from NSE public sources; figures may contain errors. Trading, especially leveraged F&O, can cause significant losses.